HLA Associations and Clinical Implications in T-Cell Mediated Drug Hypersensitivity Reactions: An Updated Review

HLA Associations and Clinical Implications in T-Cell Mediated Drug Hypersensitivity Reactions: An Updated Review

T-cell mediated drug hypersensitivity reactions may range from mild rash to severe fatal reactions. Among them, drug reaction with eosinophilia and systemic symptoms (DRESS) or drug-induced hypersensitivity syndrome (DIHS), Stevens-Johnson syndrome/ toxic epidermal necrolysis (SJS/TEN), are some of...

Descripció completa

Dades bibliogràfiques
Autors principals:	Chi-Yuan Cheng, Shih-Chi Su, Chi-Hua Chen, Wei-Li Chen, Shin-Tarng Deng, Wen-Hung Chung
Format:	Article
Idioma:	English
Publicat:	Hindawi Limited 2014-01-01
Col·lecció:	Journal of Immunology Research
Accés en línia:	http://dx.doi.org/10.1155/2014/565320

Ítems similars

HLA Association with Drug-Induced Adverse Reactions
per: Wen-Lang Fan, et al.
Publicat: (2017-01-01)

Functional and structural characteristics of HLA-B*13:01-mediated specific T cells reaction in dapsone-induced drug hypersensitivity
per: Haiqin Jiang, et al.
Publicat: (2022-08-01)

An Updated Review of the Molecular Mechanisms in Drug Hypersensitivity
per: Chun-Bing Chen, et al.
Publicat: (2018-01-01)

Erratum to “An Updated Review of the Molecular Mechanisms in Drug Hypersensitivity”
per: Chun-Bing Chen, et al.
Publicat: (2019-01-01)

Hypersensitivity Reactions to Nonsteroidal Anti-Inflammatory Drugs: An Update
per: Luis González-Aveledo, et al.
Publicat: (2010-01-01)

Drug Induced Hypersensitivity and the HLA Complex
per: Munir Pirmohamed, et al.
Publicat: (2010-12-01)

Delayed Drug Hypersensitivity Reactions: Molecular Recognition, Genetic Susceptibility, and Immune Mediators
per: Mu-Tzu Chu, et al.
Publicat: (2023-01-01)

Advances in understanding of the pathogenesis and therapeutic implications of drug reaction with eosinophilia and systemic symptoms: an updated review
per: Chun-Bing Chen, et al.
Publicat: (2023-06-01)

Genotyping for HLA Risk Alleles to Prevent Drug Hypersensitivity Reactions: Impact Analysis
per: Lisanne E. N. Manson, et al.
Publicat: (2021-12-01)

Current understanding of genetic associations with delayed hypersensitivity reactions induced by antibiotics and anti-osteoporotic drugs
per: Chih-Hsuan Wung, et al.
Publicat: (2023-04-01)

Update on pathobiology in Stevens-Johnson syndrome and toxic epidermal necrolysis
per: Shih-Chi Su, et al.
Publicat: (2013-12-01)

Clinical characteristics and genetic HLA marker for patients with oxaliplatin-induced adverse drug reactions
per: Hung-Chih Hsu, et al.
Publicat: (2024-10-01)

Genetic associations of human leukocyte antigen alleles in cutaneous delayed drug hypersensitivity reactions: An updated review
per: Chun-Bing Chen, et al.
Publicat: (2023-01-01)

Associations of HLA-A and HLA-B with vancomycin-induced drug reaction with eosinophilia and systemic symptoms in the Han-Chinese population
per: Chuang-Wei Wang, et al.
Publicat: (2022-11-01)

Repurposing HLA genotype data of renal transplant patients to prevent severe drug hypersensitivity reactions
per: Lisanne E. N. Manson, et al.
Publicat: (2023-10-01)

HLA alleles associated with asparaginase hypersensitivity in Chinese children
per: Gilbert T. Chua, et al.
Publicat: (2021-10-01)

Cytotoxic Proteins and Therapeutic Targets in Severe Cutaneous Adverse Reactions
per: Shih-Chi Su, et al.
Publicat: (2014-01-01)

Hypersensitivity reactions to small molecule drugs
per: Jiayin Han, et al.
Publicat: (2022-11-01)

The Roles of Immunoregulatory Networks in Severe Drug Hypersensitivity
per: Yun-Shiuan Olivia Hsu, et al.
Publicat: (2021-02-01)

HLA Pharmacogenetic Markers of Drug Hypersensitivity in a Thai Population
per: Nontaya Nakkam, et al.
Publicat: (2018-08-01)

Diagnostic Test Criteria for HLA Genotyping to Prevent Drug Hypersensitivity Reactions: A Systematic Review of Actionable HLA Recommendations in CPIC and DPWG Guidelines
per: Lisanne E. N. Manson, et al.
Publicat: (2020-09-01)

Hypersensitivity reactions to multiple anti-tuberculosis drugs.
per: Hong-Joon Shin, et al.
Publicat: (2021-01-01)

Desensitization for the prevention of drug hypersensitivity reactions
per: Sung-Yoon Kang, et al.
Publicat: (2022-03-01)

Variability of the Genes Involved in the Cellular Redox Status and Their Implication in Drug Hypersensitivity Reactions
per: Pedro Ayuso, et al.
Publicat: (2021-02-01)

Drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS): An update in 2019
per: Tetsuo Shiohara, et al.
Publicat: (2019-07-01)

Genetic Susceptibility of <i>HLA</i> Alleles to Non-Steroidal Anti-Inflammatory Drug Hypersensitivity in the Taiwanese Population
per: Szu-Ling Chang, et al.
Publicat: (2023-12-01)

Why drug exposure is frequently associated with T-cell mediated cutaneous hypersensitivity reactions
per: James Line, et al.
Publicat: (2023-09-01)

Genomic Risk Factors Driving Immune-Mediated Delayed Drug Hypersensitivity Reactions
per: Yueran Li, et al.
Publicat: (2021-04-01)

An Updated Review of the Diagnostic Methods in Delayed Drug Hypersensitivity
per: Ana Copaescu, et al.
Publicat: (2021-01-01)

New Advances in Drug Hypersensitivity Research and Treatment
per: Yi-Giien Tsai, et al.
Publicat: (2018-01-01)

Risk factors for drug hypersensitivity reactions in children
per: Francesca Mori, et al.
Publicat: (2024-07-01)

Drug hypersensitivity reactions and allergy in patients with mastocytosis
per: Justyna H. Czarny, et al.
Publicat: (2017-03-01)

Pharmacogenetics and predictive testing of drug hypersensitivity reactions
per: Ruwen Boehm, et al.
Publicat: (2016-10-01)

Importance of hypersensitivity in adverse reactions to drugs in the elderly
per: Maria Teresa Ventura, et al.
Publicat: (2018-04-01)

Immune-Mediated Tissue Injury (Hypersensitivity Reactions)
per: Gerald J Prud'homme
Publicat: (2020-12-01)

The Mechanistic Differences in HLA-Associated Carbamazepine Hypersensitivity
per: Gwendolin S. Simper, et al.
Publicat: (2019-10-01)

Update on mosquito bite reaction: Itch and hypersensitivity, pathophysiology, prevention, and treatment
per: Ashley Vander Does, et al.
Publicat: (2022-09-01)

Clues of HLAs, metabolic SNPs, and epigenetic factors in T cell-mediated drug hypersensitivity reactions
per: Rasol Molatefi, et al.
Publicat: (2024-07-01)

An Updated Review of Genetic Associations With Severe Adverse Drug Reactions: Translation and Implementation of Pharmacogenomic Testing in Clinical Practice
per: Chuang-Wei Wang, et al.
Publicat: (2022-04-01)

Nonsteroidal anti-inflammatory drugs-induced hypersensitivity reactions
per: Andrei Gheorghe Vicovan, et al.
Publicat: (2019-12-01)